Alexandre Mugwaneza, 69, visited his wife’s paternal cousin, who was battling prostate cancer. The image of a once-active man now frail and bedridden stayed with him. Though Mugwaneza felt fine, that ...

Summit Therapeutics' shares dropped 36% after ivonescimab data showed no significant survival benefit. Click to read if SMMT ...

A cancer treatment described as 'the best early Christmas present I could've asked for', has been given FDA and NICE approval.

Two families who had lived in the United States for years, including a child with cancer and a pregnant mother, were deported ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Linda Jackson, who is living with stage 4 metastatic cancer, is running this year's London Marathon alongside her son David ...

CytomX Therapeutics CTMX, a clinical-stage oncology company, is expected to beat first-quarter 2025 earnings when it reports ...

Patients with metastatic colorectal cancer who received frontline immune checkpoint inhibitor therapy had positive OS rates ...

ASI has announced the introduction of a new Pathology Tumor Detection model that could detect lymph node metastasis.

AACR conference chairs Lillian L. Siu, MD, and Matthew Vander Heiden, MD, PhD, share their perspectives on the event with GEN ...

Keymed Biosciences Inc. (HKEX: 02162) ('Keymed' or the 'Company') today announced CM518D1, a CDH17-targeted antibody-drug conjugate (ADC) developed by Keymed, received Investigational New Drug (IND) ...

A biotech firm based in Milton Park, Oxfordshire, has received a major boost after its T-cell therapy was awarded Breakthrough Therapy Designation by the US Food and Drug Administration, ...